GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lipidor AB (FRA:L7R) » Definitions » YoY EPS Growth

Lipidor AB (FRA:L7R) YoY EPS Growth : 36.36% (As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Lipidor AB YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Lipidor AB's YoY EPS Growth for the quarter that ended in Jun. 2024 was 36.36%.

Lipidor AB's Earnings per Share (Diluted) for the three months ended in Jun. 2024 was €-0.01.

Lipidor AB YoY EPS Growth Historical Data

The historical data trend for Lipidor AB's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lipidor AB YoY EPS Growth Chart

Lipidor AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EPS Growth
Get a 7-Day Free Trial -62.50 - -11.54 -75.86 72.55

Lipidor AB Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 80.00 36.36 - 36.36

Lipidor AB YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Lipidor AB's YoY EPS Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EPS Growth (A: Dec. 2023 )
=(Earnings per Share (Diluted) (A: Dec. 2023 )-Earnings per Share (Diluted) (A: Dec. 2022 ))/ | Earnings per Share (Diluted) (A: Dec. 2022 ) |
=(-0.014--0.051)/ | -0.051 |
=72.55 %

Lipidor AB's YoY EPS Growth for the quarter that ended in Jun. 2024 is calculated as:

YoY EPS Growth (Q: Jun. 2024 )
=(Earnings per Share (Diluted) (Q: Jun. 2024 )-Earnings per Share (Diluted) (Q: Jun. 2023 )) / | Earnings per Share (Diluted) (Q: Jun. 2023 )) |
=(-0.007--0.011)/ | -0.011 |
=36.36 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lipidor AB YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Lipidor AB's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Lipidor AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lipidor AB (FRA:L7R) » Definitions » YoY EPS Growth
Comparable Companies
XKLS:9571 XKLS:4723 XKLS:0192 XKLS:7579 XKLS:9741 XKLS:0237 XKLS:5129 XKLS:5054 XKLS:7528 XKLS:7595 LLY JNJ MRK ABBV XSWX:ROG LSE:AZN XSWX:NOVN PFE AMGN XPAR:SAN
Traded in Other Exchanges
LIPI:Sweden
Address
c/o Ekonomistubben AB, Box 55931, Stockholm, SWE, 102 16
Website
https://www.lipidor.se
Lipidor AB is a pharmaceutical development company with a pipeline of drug development projects in the preclinical and clinical phases. The company develops drugs for the treatment of skin diseases such as psoriasis, bacterial skin infections, and atopic dermatitis.

Lipidor AB Headlines

No Headlines